ADIPOQ and ovarian cancer: The results of a number of studies show that serum leptin and adiponectin levels are associated with an increase in the frequency of ovarian cancer in an inverse manner, i.e., increased leptin levels and decreased adiponectin levels have a pro-cancerogenic effect [114].